VX-702
Product Specifications
CAS Number
745833-23-2
Target
Autophagy, p38 MAPK
Related Pathways
Autophagy, MAPK
Purity
>99.99%
Bioactivity
VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA) .
Smiles
NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F
Molecular Formula
C19H12F4N4O2
Molecular Weight
404.32
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15337460 1 Vial
Lentiviral human IREB2 shRNA (UAS) - Lentiviral human IREB2 shRNA (UAS) (25)
Sign In for Pricing
View Details MBS7040933-01 0.02 mg
Recombinant Uncharacterized protein C05B5.8 (C05B5.8)
Sign In for Pricing
View Details MBS7040933-02 0.1 mg
Recombinant Uncharacterized protein C05B5.8 (C05B5.8)
Sign In for Pricing
View Details 
MBS7040933-03 5x 0.1 mg
Recombinant Uncharacterized protein C05B5.8 (C05B5.8)
Sign In for Pricing
View Details